
FORNARI CARLA
- U38, Piano: 5, Stanza: 5019
Pubblicazioni
Cortesi, P., Fornari, C., Boncristiano, A., Facchetti, R., Balestrini, S., Doccini, V., et al. (2026). Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study. EPILEPSIA OPEN, 11(1), 250-258 [10.1002/epi4.70200]. Dettaglio
Zamagni, G., Carreras, G., Armocida, B., Gakidou, E., Ashbaugh, C., Alicandro, G., et al. (2026). National and subnational burden of disease attributable to risk factors in Italy, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023. THE LANCET PUBLIC HEALTH, 11(5), 293-305 [10.1016/S2468-2667(26)00048-4]. Dettaglio
Zamagni, G., Armocida, B., Castelpietra, G., Conti, S., Cortesi, P., Ferrara, P., et al. (2026). Il carico di malattia in Italia, dal 1990 al 2023: un’analisi regionale dal Global Burden of Disease Study 2023. EPIDEMIOLOGIA E PREVENZIONE, 50(1), 67-77 [10.19191/EP26.1.A991.020]. Dettaglio
Negri, S., Fornari, C., Ye, L., Inzoli, A., Costa, C., Mantovani, L., et al. (2026). Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS [10.1007/s10198-026-01909-4]. Dettaglio
Antonazzo, I., Fornari, C., Zamparini, M., Crotti, G., Zucchi, A., Ferrara, P., et al. (2026). Changes in youth public psychiatric service utilization during the COVID-19 pandemic in Italy: an observational study. FRONTIERS IN PHARMACOLOGY, 17 [10.3389/fphar.2026.1708009]. Dettaglio